What is Tirzepatide?
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied across metabolic, appetite, and body-composition research.
Tirzepatide dosage snapshot
- Route
- subQ
- Dose range
- 2.5-15 mg titrated
- Frequency
- 1x weekly
- Duration
- long-term studies
Based on reported research sources; not a dosing instruction.
Potential benefits
- Weight loss
- Glucose control
- Appetite control
- Metabolic health
- Body composition
Safety profile
Low risk- Common: Nausea, diarrhea, vomiting, constipation, and appetite suppression.
- Less common: Injection-site reactions, fatigue, reflux, or abdominal discomfort.
- Caution: Dose escalation and prior incretin exposure can strongly affect tolerability.
Storage and handling
Store according to product-label instructions and batch handling notes. Lyophilized research peptides are commonly kept dry, protected from light, and handled with clean laboratory technique.